Analyst Ranking
Top 27%
#1439 out of 5493 analysts
Average Return
+5.5%
Win Rate
56%20 out of 36
Risk vs Reward
Poor
Good

Vik Chopra's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Alphatec Holdings IncATEC
+59.34%$6.64$10.58
2024-08-01 -
2025-07-31
Strong Buy
Neuropace IncNPCE
+56.22%$9.32$14.56
2025-08-13 -
2026-08-12
Strong Buy
Neuropace IncNPCE
+47.54%$9.15$13.50
2024-11-13 -
2025-11-12
Strong Buy
Globus Medical IncGMED
+40.41%$58.65$82.35
2025-08-08 -
2026-08-07
Strong Buy
Neuropace IncNPCE
+37.67%$6.77$9.32
2024-08-14 -
2025-08-13
Strong Buy

Vik Chopra's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Alphatec Holdings IncATEC
4Buy$12.00+23.08%Maintains
9 days ago
Envista Holdings CorpNVST
5Hold$27.00-3.85%Initiates Coverage On
a month ago
Zimmer Biomet Holdings IncZBH
1Hold$95.00-4.59%Initiates Coverage On
a month ago
Integra Lifesciences Holdings CorpIART
4Hold$19.00+4.17%Initiates Coverage On
a month ago
Intuitive Surgical IncISRG
1Buy$518.00+29.09%Initiates Coverage On
a month ago
Teleflex IncTFX
1Buy$159.00+15.75%Initiates Coverage On
a month ago
Enovis CorpENOV
6Buy$29.00+13.02%Initiates Coverage On
a month ago
Align Technology IncALGN
6Buy$209.00+18.62%Initiates Coverage On
a month ago
Solventum CorpSOLV
6Hold$83.00-4.00%Maintains
6 months ago
Dentsply Sirona IncXRAY
5Hold$13.00+12.26%Maintains
6 months ago
Globus Medical IncGMED
12Strong Buy$104.00+21.01%Maintains
6 months ago
Henry Schein IncHSIC
4Hold$87.00-3.46%Maintains
6 months ago
Masimo CorpMASI
11Hold$180.00+0.03%Downgrades
6 months ago
Conmed CorpCNMD
7Hold$42.00-15.70%Maintains
7 months ago
Neuropace IncNPCE
4Strong Buy$16.00+10.27%Maintains
9 months ago
Nuvasive IncNUVA
2Hold$57.72N/ADowngrades
4 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.